{"slideshow_credits": null, "snippet": "The transaction would be the latest in an acquisition spree by Shire since its tentative agreement to be bought by the drug maker AbbVie was terminated.", "abstract": "Irish drug maker Shire agrees to acquire American biotechnology firm Dyax Corporation for up to $6.5 billion.", "section_name": "Business Day", "print_page": "11", "document_type": "article", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://www.nytimes.com/2015/11/03/business/dealbook/shire-dyax-corp-deal.html", "lead_paragraph": "The transaction would be the latest in an acquisition spree by Shire since its tentative agreement to be bought by the drug maker AbbVie was terminated.", "headline": {"main": "Irish Drug Maker Shire Agrees to Buy Dyax in Deal Worth Up to $6.5 Billion", "print_headline": "Irish Drug Maker Shire Agrees to Buy Dyax in Deal Worth Up to $6.5 Billion"}, "_id": "56376b0f38f0d829bdc68687", "word_count": "457", "multimedia": [{"height": 126, "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/03/business/db-shire-web1/db-shire-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Dyax Corporation", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Shire PLC", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "AbbVie Inc", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Baxter International", "is_major": "N", "rank": "7"}, {"name": "organizations", "value": "NPS Pharmaceuticals Inc", "is_major": "N", "rank": "8"}, {"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}